THEMES AND PROGRAMME OF THE MEETING
|
|---|
Thursday 26th November 2009 |
||
9.00 - 10.00 |
Registration and coffee |
|
Session 1 – Reducing Morbidity: Advances in Radiotherapy and Imaging |
||
10.00 - 10.30 |
Late consequences of pelvic radiotherapy – prevention, identification and management |
Prof Jane Maher |
10.30 - 11.00 |
Image guided radiotherapy – Can it increase effectiveness |
Dr Alex Taylor |
11.00 - 11.30 |
New Technologies in Imaging; can they improve outcomes? |
Dr Mary Keogan |
11:30 – 12:15 |
Proffered papers |
|
11:35 – 11:45 |
1. Application of IR spectroscopy gives a diagnostic signature of endometrial cancer |
S Taylor
|
11:45 – 12:00 |
2.The role of multi modality imaging in radiotherapy treatment for women with cervical cancer |
R Shireen |
12:00 – 12:15 |
3.The role of PET CT and primary tumour SUVmax in staging and predicting disease extent in cervical cancer – single institutional experience |
L Walsh |
12.15 - 13.30 |
Lunch / Posters / Exhibitions |
|
Session 2 – Reducing Morbidity: Quality of Life Issues and Gynaecological Cancer |
||
13.30 - 14.00 |
Quality of Life in Gynaecological Cancer focussing on Ovarian Cancer and Obstruction |
Dr Tito Lopes |
14.00 - 14.30 |
The Costs of having Cancer |
Dr Linda Sharpe |
14.30 - 15.00 |
The Psychosexual Impact on women with Gynaecological Cancer (Prof Graziottin’s paper will be presented by Dr Niccolo Giovannini) |
Prof Alessandra Graziottin |
15.00 - 16.15 |
Proffered papers / MDT |
|
15:00 – 15:15 |
1. Psychosocial impact of HPV related diseases inUK, the PasQual study |
A Fiander |
15:15 – 15:30 |
2. Cardiff Malignancy Index ; a role for doppler ultrasound in the triage of pelvic masses |
A Treharne |
15:30 – 15:45
|
3. Increasing incidence of invasive cervical cancer in young women after the change in policy of commencing smear to 25 years |
A Patel
|
15:45 – 16:00
|
4. Surgical management and follow up of patients with cervical cancer : survey of gynaecological oncologists in the UK |
M Nobbenhuis |
16.00 - 17.00 |
Tea / Coffee /Posters / Exhibitions |
|
17.00 |
A G M |
|
Friday 27th November 2009 |
||
|
Session 3 – Reducing the Burden of Ovarian Cancer; What’s the future for Prevention? |
|
09.00 - 09.30 |
Screening for Ovarian Cancer; where are we at? |
Prof Ian Jacobs |
09.30 - 10.00 |
Lifestyle, molecular pathology and ovarian cancer risk |
Prof Karin Jirstrom |
10.00 - 11.00 |
Proffered Papers |
|
10:00 – 10:15 |
1. miR-187 is a Marker of platinum resistance in epithelial ovarian cancer |
D Brennan |
10:00 – 10:15 |
2. The role of androgen receptor as a clinical biomarker in epithelial ovarian cancer |
A Elattar |
10:15 – 10:30 |
3. Uptake and outcomes of risk reducing surgery for ovarian cancer in high risk women with gene mutations and those with unknown mutation status |
R Manchanda |
10:30 – 10:45 |
4. UK familial ovarian cancer screening study phase 1 – results of annual screening |
A Rosenthal |
11.00 - 11.30 |
Tea / Coffee /Posters / Exhibitions |
|
11.30 - 13.30 |
Proffered papers |
|
11:30 – 11:45 |
1. Polymer coating reduces innate immune responses to oncolytic adenovirus |
J Morrison |
11:45 – 12:00 |
2. Differential expression of PPARs and RXRs in endometrial carcinoma and effects of PPAR –a and –y gene silencing on cellular growth |
M Nickkho-Amiry |
12:00 – 12:15 |
3. Targeted chemotherapy in ovarian cancer: exploring the role of homologous recombination |
A Mukhopadhyay |
12:15 – 12:30 |
4. Surgical radicality of the total laparoscopic hysterectomy compared to the open radical hysterectomy |
E Moss
|
12:30 – 12:45
|
5. An audit cycle is an effective tool in improving pain scores in patients undergoing major gynaecological oncology surgery |
L Findlay |
12:45 – 13:00 |
6. Total laparoscopic hysterectomy for low grade endometrial cancer and atypia |
M Roberts |
13:00 – 13:15 |
7. One stage combined gynaecoplastic risk reducing surgery; a service review |
M McComiskey |
13:15 – 13:30 |
8. Ultra radical procedures and morbidity in Gynaecological Oncology surgery |
A Patel |
13.30 - 14.30 |
Lunch / Posters / Exhibitions |
|
Session 4 – Reducing the Burden: Advances in Surgery |
|
|
14.30 - 15.00 |
Laparoscopic Exenteration – An Achievable Reality? (Dr Ferron’s paper will be presented by Dr Alejandra Martinez) |
Dr Gwen Ferron |
15.00 - 15.45 |
Robotic Surgery and Gynaecological Cancer – Is there a Role? |
Dr John Boggess |
Session 5 – Clinical Trials |
|
|
15.45 - 16.15 |
Clinical Trial Updates |
Prof Sean Kehoe |
16.15 - 17.00 |
Tea / Coffee /Posters / Exhibitions |
|
 |
 |
 |
 |
 |